These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2887995)

  • 61. Spectral and inhibitory interactions of (+/-)-3,4-methylenedioxyamphetamine (MDA) and (+/-)-3,4-methylenedioxymethamphetamine (MDMA) with rat hepatic microsomes.
    Brady JF; Di Stefano EW; Cho AK
    Life Sci; 1986 Oct; 39(16):1457-64. PubMed ID: 2877380
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ring-substituted amphetamine interactions with neurotransmitter receptor binding sites in human cortex.
    Pierce PA; Peroutka SJ
    Neurosci Lett; 1988 Dec; 95(1-3):208-12. PubMed ID: 2906416
    [TBL] [Abstract][Full Text] [Related]  

  • 63. (+/-)-3,4-Methylenedioxymethamphetamine-induced changes in the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons.
    Kelland MD; Freeman AS; Chiodo LA
    Eur J Pharmacol; 1989 Oct; 169(1):11-21. PubMed ID: 2574685
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The antinociceptive effects of 3,4-methylenedioxymethamphetamine (MDMA) in the rat.
    Crisp T; Stafinsky JL; Boja JW; Schechter MD
    Pharmacol Biochem Behav; 1989 Nov; 34(3):497-501. PubMed ID: 2576139
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effects of MDMA and other methylenedioxy-substituted phenylalkylamines on the structure of rat locomotor activity.
    Paulus MP; Geyer MA
    Neuropsychopharmacology; 1992 Aug; 7(1):15-31. PubMed ID: 1355968
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalanine accumulation in the striatum and nucleus accumbens.
    Nash JF; Meltzer HY; Gudelsky GA
    J Neurochem; 1990 Mar; 54(3):1062-7. PubMed ID: 1689375
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Designer drug confusion: a focus on MDMA.
    Beck J; Morgan PA
    J Drug Educ; 1986; 16(3):287-302. PubMed ID: 2877058
    [No Abstract]   [Full Text] [Related]  

  • 68. Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate.
    Slikker W; Holson RR; Ali SF; Kolta MG; Paule MG; Scallet AC; McMillan DE; Bailey JR; Hong JS; Scalzo FM
    Neurotoxicology; 1989; 10(3):529-42. PubMed ID: 2576304
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Actions of amphetamine derivatives and cathinone at the noradrenaline transporter.
    Cleary L; Docherty JR
    Eur J Pharmacol; 2003 Aug; 476(1-2):31-4. PubMed ID: 12969746
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vitro reactivation of rat cortical tryptophan hydroxylase following in vivo inactivation by methylenedioxymethamphetamine.
    Stone DM; Hanson GR; Gibb JW
    J Neurochem; 1989 Aug; 53(2):572-81. PubMed ID: 2568404
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.
    Nash JF; Meltzer HY; Gudelsky GA
    J Pharmacol Exp Ther; 1988 Jun; 245(3):873-9. PubMed ID: 2898523
    [TBL] [Abstract][Full Text] [Related]  

  • 72. 3,4-Methylenedioxymethamphetamine-induced release of serotonin and inhibition of dorsal raphe cell firing: potentiation by L-tryptophan.
    Sprouse JS; Bradberry CW; Roth RH; Aghajanian GK
    Eur J Pharmacol; 1990 Mar; 178(3):313-20. PubMed ID: 1971220
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prepulse inhibition of the acoustic startle response is disrupted by N-ethyl-3,4-methylenedioxyamphetamine (MDEA) in the rat.
    Mansbach RS; Braff DL; Geyer MA
    Eur J Pharmacol; 1989 Aug; 167(1):49-55. PubMed ID: 2776841
    [TBL] [Abstract][Full Text] [Related]  

  • 74. MDMA-like stimulus effects of alpha-ethyltryptamine and the alpha-ethyl homolog of DOM.
    Glennon RA
    Pharmacol Biochem Behav; 1993 Oct; 46(2):459-62. PubMed ID: 7903460
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats.
    Finnegan KT; Skratt JJ; Irwin I; Langston JW
    Neurosci Lett; 1989 Nov; 105(3):300-6. PubMed ID: 2574428
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Subjective reports of the effects of MDMA in a clinical setting.
    Greer G; Tolbert R
    J Psychoactive Drugs; 1986; 18(4):319-27. PubMed ID: 2880946
    [No Abstract]   [Full Text] [Related]  

  • 77. Application of entropy measures derived from the ergodic theory of dynamical systems to rat locomotor behavior.
    Paulus MP; Geyer MA; Gold LH; Mandell AJ
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):723-7. PubMed ID: 1967830
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Steric effects of substituents on phenethylamine hallucinogens. 3,4-(Methylenedioxy)amphetamine analogues alkylated on the dioxole ring.
    Nichols DE; Kostuba LJ
    J Med Chem; 1979 Oct; 22(10):1264-7. PubMed ID: 513074
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Advantages and disadvantages of a rapid method to train drug discrimination.
    Schechter MD
    Pharmacol Biochem Behav; 1988 Sep; 31(1):239-42. PubMed ID: 2908064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.